PBSV · Pharma-Bio Serv, Inc.
4 customers — 19.8% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 19.8% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 18.5% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 18.5% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 16.5% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 16.5% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 16.1% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 16.1% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 14.6% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 14.2% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 12.9% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 12.4% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 7.4% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 7.4% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 5.9% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 5.9% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 47.1% of receivables (April 30, 2026)
“On April 30, 2026, amounts due from these customers represented 47.1% of the Company’s total accounts receivable balance.”
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.